These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1573 related items for PubMed ID: 7667166

  • 21. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus.
    Romics L, Karádi I, Rozenberczki M, Kammerer L.
    Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327
    [Abstract] [Full Text] [Related]

  • 22. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 23. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV, Frick KD, Wade A, Simko R, Burge R.
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [Abstract] [Full Text] [Related]

  • 24. Are plasma lipoproteins responsible for the excess atherosclerosis in diabetes?
    Nikkilä EA.
    Acta Endocrinol Suppl (Copenh); 1985 Apr; 272():27-30. PubMed ID: 3869424
    [Abstract] [Full Text] [Related]

  • 25. [Dyslipidemia in diabetes mellitus: significance, diagnosis and treatment].
    Keller U, Golay A, Pometta D.
    Schweiz Rundsch Med Prax; 1990 Oct 09; 79(41):1199-204. PubMed ID: 2237046
    [Abstract] [Full Text] [Related]

  • 26. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S.
    Clin Ther; 2008 Feb 09; 30(2):294-306. PubMed ID: 18343268
    [Abstract] [Full Text] [Related]

  • 27. Niacin-based therapy for dyslipidemia: past evidence and future advances.
    Ito MK.
    Am J Manag Care; 2002 Sep 09; 8(12 Suppl):S315-22. PubMed ID: 12240703
    [Abstract] [Full Text] [Related]

  • 28. Hypertriglyceridemia in diabetes. An approach to management.
    Fisher WR.
    J Fla Med Assoc; 1991 Nov 09; 78(11):747-50. PubMed ID: 1765754
    [Abstract] [Full Text] [Related]

  • 29. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    Arterioscler Thromb Vasc Biol; 2004 Aug 09; 24(8):e149-61. PubMed ID: 15297292
    [Abstract] [Full Text] [Related]

  • 30. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ, Coordinating Committee of the National Cholesterol Education Program.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):720-32. PubMed ID: 15358046
    [Abstract] [Full Text] [Related]

  • 31. [Dyslipidemia in diabetes mellitus].
    Niemeijer-Kanters SD, Banga JD, Erkelens DW.
    Ned Tijdschr Geneeskd; 2001 Apr 21; 145(16):769-74. PubMed ID: 11346913
    [Abstract] [Full Text] [Related]

  • 32. Hyperlipidemia in children with type 2 diabetes mellitus.
    Taha D.
    J Pediatr Endocrinol Metab; 2002 Apr 21; 15 Suppl 1():505-7. PubMed ID: 12017224
    [Abstract] [Full Text] [Related]

  • 33. Diabetic dyslipidemia.
    Kreisberg RA.
    Am J Cardiol; 1998 Dec 17; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [Abstract] [Full Text] [Related]

  • 34. [Lipid-lowering therapy in patients with type-2 diabetes mellitus].
    Pados G, Audikovszky M.
    Orv Hetil; 2003 Mar 23; 144(12):557-61. PubMed ID: 12723526
    [Abstract] [Full Text] [Related]

  • 35. Diabetic dyslipidemia: a case for aggressive intervention in the absence of clinical trial and cost effectiveness data.
    Lewis GF.
    Can J Cardiol; 1995 May 23; 11 Suppl C():24C-28C. PubMed ID: 7750045
    [Abstract] [Full Text] [Related]

  • 36. [Women and ischemic cardiopathy].
    Assmann G, Davignon J, Fernández Cruz A, Gotto AM, Jacotot B, Lewis B, Paoletti R.
    Rev Clin Esp; 1989 Oct 23; 185(6):308-15. PubMed ID: 2695994
    [Abstract] [Full Text] [Related]

  • 37. [Different forms of hyperlipoproteinemia in diabetics (author's transl)].
    Vogt N, Englhardt A.
    Med Klin; 1975 Nov 14; 70(46):1871-7. PubMed ID: 171548
    [Abstract] [Full Text] [Related]

  • 38. The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.
    Brunetti L, Hermes-Desantis ER.
    Ann Pharmacother; 2010 Nov 14; 44(7-8):1196-206. PubMed ID: 20551301
    [Abstract] [Full Text] [Related]

  • 39. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
    Schwandt P.
    Klin Wochenschr; 1990 Nov 14; 68 Suppl 22():54-8. PubMed ID: 2087080
    [Abstract] [Full Text] [Related]

  • 40. The effects of glibenclamide and insulin on plasma high density lipoprotein in diabetics.
    Tamai T, Nakai T, Yamada S, Kobayashi T, Hayashi T, Kutsumi Y, Oida K, Takeda R.
    Artery; 1981 Nov 14; 9(6):477-93. PubMed ID: 6802107
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 79.